Guidance

Live attenuated influenza vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated influenza vaccine (Fluenz Trivalent®) in accordance with the national seasonal influenza vaccination programme.

• From: UK Health Security Agency
• Published: 10 July 2024

Applies to England

Documents

Influenza vaccine (Fluenz Trivalent®): patient group direction (PGD) template

Ref: UKHSA gateway number GOV-16524

MS Word Document, 445 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of the national seasonal influenza vaccination programme.

LAIV PGD version 14.00 is valid from 1 September 2024 to 1 April 2025.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 10 July 2024